&nbsp;

FormulaSedentaryTime-FR.JPG

Dec 1969

Document

FITLabReportsPrimary.pdf

Mar 2022

Document

neilJohnson.jpg

Mar 2022

Regimen

NPAC(W)+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

Regimen

NPAC+PERTRAS(SC)

Cancer Type:

Breast

Intent: Palliative

Funding:

New Drug Funding Program

Nab-Paclitaxel - Metastatic Breast Cancer

Drugs Used:

PERTuzumab / trastuzumab (subcut) (Unfunded),

nab-PACLitaxel (Unfunded with exceptions)

Quick Link(s):

Regimen Monograph

Regimen

NIVL

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab - Adjuvant Treatment of Urothelial Carcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Regimen

NIVL(MNT)

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab - First-line Treatment of Advanced Gastric, Esophageal, and Esophagogastric Junction Adenocarcinoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Cancer facts

Firefighters in Ontario at increased risk of certain cancers

Nov 2022

Document

food-literacy-en.png

Jan 2023

Document

food-literacy-fr.png

Jan 2023

Regimen

FEC+PEMB

Cancer Type:

Breast

Intent: Neoadjuvant

Funding:

New Drug Funding Program

Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Drugs Used: